BA
The Boeing Company
BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CHRW
C.H. Robinson Worldwide, Inc.
CHRW has a slight edge over BA overall, supported by stronger modeled upside and lower modeled downside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CHRW Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Stable |
CHRW's revenue and profitability are currently healthy, and its balance sheet is stable, but its cash flow is under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CHRW in the historical PE scenario, which offers more potential upside but is not a forecast.
CHRW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $85.25 | -37% |
| Forward | 18x | $134 | — |
| Fair | 24x | $132 | -1.6% |
| Current | 24x | $134 | — |
| Expensive | 34x | $188 | +40% |
Historical ranges are pointers, not guarantees.
CHRW's PE is in its fair range at 24x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over CHRW on the outlook, with more favorable profitability expectations.
CHRW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CHRW, with profitability holding steady.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
CHRW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.30 | +31% |
| Q3 2026 | $5.57 | +13% |
| Q2 2026 | $5.24 | +19% |
| Q1 2026 | $4.94 | +18% |
| Q4 2025 | $4.83 | +25% |
| Q3 2025 | $4.94 | +70% |
| Q2 2025 | $4.40 | +58% |
| Q1 2025 | $4.19 | +65% |
| Q4 2024 | $3.86 | +42% |
CHRW has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over CHRW on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CHRW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.4B | +30% |
| Q2 2026 | $4.9B | +19% |
| Q1 2026 | $4B | -0.8% |
| Q4 2025 | $3.9B | -6.5% |
| Q3 2025 | $4.1B | -11% |
| Q2 2025 | $4.1B | -7.7% |
| Q1 2025 | $4B | -8.3% |
| Q4 2024 | $4.2B | -0.9% |
CHRW's revenue is recovering but still below its 2022 peak: $5.4B last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.1% | -0.3 points |
| Q2 2026 | 5.2% | 0 points |
| Q1 2026 | 4.4% | 0 points |
| Q4 2025 | 4.6% | +0.3 points |
| Q3 2025 | 5.3% | +1.5 points |
| Q2 2025 | 5.2% | +1.2 points |
| Q1 2025 | 4.4% | +1.5 points |
| Q4 2024 | 4.4% | +1.8 points |
CHRW has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CHRW on cash flow, with more consistent year-over-year improvement.
CHRW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $120.5M | -55% |
| Q2 2026 | $30.9M | -86% |
| Q1 2026 | $66M | -36% |
| Q4 2025 | $302.4M | +14% |
| Q3 2025 | $269.5M | +161% |
| Q2 2025 | $219.8M | +38% |
| Q1 2025 | $103.2M | +$145.1M |
| Q4 2024 | $265.3M | +514% |
CHRW still generates free cash flow, though less than at its 2022 peak: $520M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CHRW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -1M shares |
| 1 year | -2.2% | -2.6M shares |
| 3 years | -0.9% | -1M shares |
| 5 years | -11% | -14.7M shares |
| Available history | -13% | -17.9M shares |
CHRW has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $207.7M |
| Q2 2026 | $219.5M |
| Q1 2026 | $212.7M |
| Q4 2025 | $114.4M |
| Q3 2025 | $111.5M |
| Q2 2025 | $81.1M |
| Q1 2025 | $47.7M |
| Q4 2024 | — |
CHRW spent $754M buying back its own shares over the past year, about three times what it spent the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CHRW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 1.3x | Healthy |
| Q4 2025 | 1.0x | Healthy |
| Q3 2025 | 1.2x | Healthy |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.6x | Healthy |
CHRW has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CHRW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.0 | Neutral |
| Stochastic | 15.4 | Oversold |
CHRW's weekly RSI is 41 (neutral) and its Stochastic is 15 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over CHRW on valuation relative to its sector.
CHRW PE vs Industrials Sector
| Metric | CHRW | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 0.2% above |
| PE % | 51 | 58 | 7 pts below |
CHRW is trading at 24x earnings, in line with the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CHRW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $139.0 | 3.3% below |
| 20 week MA | $154.1 | 13% below |
| 50 week MA | $166.9 | 19% below |
| 100 week MA | $139.0 | 3.3% below |
| 200 week MA | $115.3 | 17% above |
CHRW has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CHRW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.9 | $94.7 | +21% |
| 2021 | $94.7 | $102.5 | +8.2% |
| 2022 | $102.5 | $93.1 | -9.1% |
| 2023 | $93.1 | $86.4 | -7.2% |
| 2024 | $86.4 | $103.9 | +20% |
| 2025 | $103.9 | $164.6 | +58% |
| 2026 YTD | $164.6 | $134.4 | -18% |
CHRW has the edge over BA on returns for 2026, with the stronger performance.